PCAR vs RLMD · P/E 25, rev $33.66B vs $692.3M cap
PACCAR Inc (PCAR) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
RLMD does not have a complete income-statement cache yet.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the PCAR and RLMD stock pages for the full models.
Not investment advice.